Stay updated on Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Sign up to get notified when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page reflects a change in the site/system revision label, indicating an interface or platform version update without modifying the underlying clinical trial record details.
    Difference
    0.1%
    Check dated 2026-04-25T06:18:02.000Z thumbnail image
  3. Check
    23 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added a Study Status entry and removed an older version date in the record history.
    Difference
    0.2%
    Check dated 2026-04-03T19:24:19.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision history updated to include v3.5.0 and remove v3.4.3. This appears to be a UI/backend update with no changes to study data or functionality.
    Difference
    0.1%
    Check dated 2026-03-20T06:38:03.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed in the study record history.
    Difference
    0.1%
    Check dated 2026-03-05T19:44:03.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added and an older revision (v3.4.1) was removed. The latest version also includes the 'Study Status' section in the history view.
    Difference
    0.3%
    Check dated 2026-02-12T02:06:14.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The history shows a new revision entry for v3.4.1 and the deletion of the previous revision v3.4.0. It reflects an administrative update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-02-04T22:50:41.000Z thumbnail image

Stay in the know with updates to Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1/2 Pacritinib & Sirolimus for GVHD Prevention Clinical Trial page.